Andy von Eschenbach
Showing 1–3 of 3 transcripts.
- Milken Institute1h 4m
Big Data for Better Cures: Where to Invest?
Cecilia Arradaza, Marty Cohn, Joel Dudley, Magali Haas, Risa Sack, Andy von Eschenbach, Harlan Weissman, Garrett, Mary Dwight
Leading healthcare experts including Marty Cohn, Joel Dudley, and Andy von Eschenbach converged to identify that while big data offers potential to reduce waste and personalize care, its adoption is currently stifled by incentive misalignment, fragmented data silos, and a regulatory framework built on pre-market rather than post-market surveillance. The panel consensus highlighted that shifting from fee-for-service to value-based care and establishing a "model of the normal" human are critical prerequisites for unlocking predictive analytics in chronic disease and neurology. To advance these goals, the speakers urged the creation of broad consent models, common data standards for cross-organizational sharing, and new reimbursement structures that specifically reward data utility over collection.
- Milken Institute51 min
The 2014 Atlanta Summit - - Race We Can't Afford to Lose: Outsmarting Superbugs
Larry Brilliant, Beth Bell, Victoria Nahum, Lance Price, Andy von Eschenbach
Public health leaders convened to address the critical obsolescence of U.S. disease surveillance technology, which currently lags behind the rapid, cost-effective capabilities of Advanced Molecular Detection required to combat antimicrobial resistance and food-borne threats. Panelists detailed the catastrophic societal costs of preventable infections, including specific cases where delayed diagnostics contributed to mortality, while arguing that federal inaction represents the single greatest immediate risk to national security and public safety. The discussion concluded with a unified call for mandatory antibiotic stewardship, standardized genomic testing, and medical diplomacy to secure global health infrastructure before emerging pathogens outpace current diagnostic limitations.
- Milken Institute1h 15m
The Promise of the Bioscience Century
Paul Irving, Mike Milken, Eric Cantor, Paul Chu, Jeff, Bernardo Zavala, Jr., Bernard Harris, Andy von Eschenbach, Peggy, Francis Collins, Chris Austin
This event analyzes the critical role of bioscience in driving global economic growth and societal well-being while highlighting China's aggressive $308 billion investment program that threatens to surpass U.S. leadership. Panelists discuss strategic institutional responses, such as DARPA's high-risk research model and the FDA's regulatory innovations, which have accelerated breakthroughs in prosthetics, personalized medicine, and disease prevention. However, fiscal constraints and shifting global demographics necessitate sustained bipartisan funding to preserve the United States' status as a central hub for scientific innovation and global health security.